SCHEMBL6440437

SCHEMBL6440437

CCOc1cc2c(cc1OC)C(c1ccc(C(=O)Cl)cc1)=NC1CCN(C)CC21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.79
PDE4A P27815 2/20 0.79
PDE4B Q07343 1/20 0.79
PDE4C Q08493 1/20 0.79
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ATM Q13315 1/20 0.35
KMT2A Q03164 5/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
KDM4E B2RXH2 2/20 0.35
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
CHRM1 P11229 1/20 0.33
PDE3A Q14432 1/20 0.33
MAPK1 P28482 1/20 0.33
PROKR1 Q8TCW9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3551034 1.00 PDE4D (0.79) PDE4DPDE4APDE4BPDE4CHPGD
Hydrochloric Acid SCHEMBL6442735 0.99 PDE4D (0.78) PDE4DPDE4APDE4BPDE4CHPGD
Hydrochloric Acid SCHEMBL6442741 0.99 PDE4D (0.78) PDE4DPDE4APDE4BPDE4CHPGD
SCHEMBL3554997 0.93 PDE4D (0.81) PDE4DPDE4APDE4BPDE4CHPGD
SCHEMBL5510164 0.93 PDE4D (0.81) PDE4DPDE4APDE4BPDE4CHPGD
SCHEMBL6440046 0.93 PDE4D (0.81) PDE4DPDE4APDE4BPDE4CHPGD
SCHEMBL3555816 0.93 PDE4D (0.81) PDE4DPDE4APDE4BPDE4CHPGD
Hydrochloric Acid SCHEMBL3555869 0.92 PDE4D (0.80) PDE4DPDE4APDE4BPDE4CHPGD
SCHEMBL13658117 0.92 PDE4D (0.80) PDE4DPDE4APDE4BPDE4CHPGD
Hydrochloric Acid SCHEMBL3555873 0.92 PDE4D (0.80) PDE4DPDE4APDE4BPDE4CHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936622-B2 6-phenylbenzonaphthyridines ALTANA PHARMA AG (DE) 2005-08-30 US disclosed
EP-1377574-B1 6-PHENYLBENZONAPHTHYRIDINES BYK GULDEN LOMBERG CHEM FAB (DE) 2005-01-19 EP disclosed
US-20040097537-A1 6-phenylbenzonaphthyridines TAKEDA GMBH (DE) 2004-05-20 US disclosed
WO-2002066476-A9 6-PHENYLBENZONAPHTHYRIDINES ALTANA PHARMA AG (DE) 2003-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097537-A1 6-phenylbenzonaphthyridines PDE3A, PDE4A, PDE3B PDE4D 7/4885PDE4A 2/4885PDE4B 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.